<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87-viruses-12-00862">
 <label>87.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rudenko</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kiseleva</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Krutikova</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Stepanova</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Rekstin</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Donina</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pisareva</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Grigorieva</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kryshen</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Muzhikyan</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model</article-title>
  <source>PLoS ONE</source>
  <year>2018</year>
  <volume>13</volume>
  <elocation-id>e0208028</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0208028</pub-id>
  <pub-id pub-id-type="pmid">30507951</pub-id>
 </element-citation>
</ref>
